Modern Authentication of Pharmaceuticals Act of 2022
Official title: To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the House Committee on Energy and Commerce.
Modern Authentication of Pharmaceuticals Act of 2022
This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. The bill applies to products manufactured on or after January 1, 2026.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 7653: Modern Authentication of Pharmaceuticals Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-7653/
"H.R. 7653: Modern Authentication of Pharmaceuticals Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-7653/.
H.R. 7653, 117th Cong. (2026), https://openamerica.io/bill/117-HR-7653/.
[H.R. 7653: Modern Authentication of Pharmaceuticals Act of 2022](https://openamerica.io/bill/117-HR-7653/)